Pro Medicus Limited

Price Chart

Risk-Adjusted Performance

Pro Medicus Limited (PMCUF) Price Performance

Pro Medicus Limited (PMCUF) trades on United States in USD. The company is classified in the Healthcare sector under the Health Information Services industry. The stock currently trades at $85.45, down 3.13% from the previous close.

Over the past year, PMCUF has traded between a low of $76.33 and a high of $217.91. The stock has lost 32.1% over this period. It is currently 60.8% below its 52-week high.

Pro Medicus Limited has a market capitalization of $9.65B and a dividend yield of 48.00%.

About Pro Medicus Limited

Pro Medicus Limited, a healthcare informatics company, engages in the development and supply of healthcare imaging software, and radiology information (RIS) system software and services to hospitals, imaging centers, and health care groups in Australia, North America, and Europe. The company offers Visage RIS Visage 7 Enterprise Imaging Platform, a healthcare imaging software that provides radiologists, physicians, and clinicians with access and visualization capability for viewing 2-D, 3-D, and 4-D medical images; and picture archive and communication system (PACS)/digital imaging software. It also provides Visage RIS, a proprietary medical software for practice management, training, installation, professional services, and after-sale support and service products; and Promedicus.net, an e-health platform for secure email and integration products. In addition, the company offers Visage Ease, a mobile application that provides users access to medical imaging results; and Visage Ease Pro, a mobile application that provides users the ability to interpret various diagnostic imaging studies stored on a Visage 7 server. Pro Medicus Limited was incorporated in 1983 and is headquartered in Richmond, Australia.